Blog
RSS FeedPosted by Michael Wonder on 29 Sep 2018
New Zealand Pharmaceutical Schedule - 1 October 2018 update
1 October 2018 - The October 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 28 Sep 2018
Decision to fund sapropterin
28 September 2018 - PHARMAC is pleased to announce a decision to list sapropterin (Kuvan), a treatment for the rare ...
Posted by Michael Wonder on 26 Sep 2018
PHARMAC urged to subsidise cost prohibitive but 'highly effective' contraceptive option
26 September 2018 - The Mirena is a popular and effective contraceptive option but it's $340 price tag has been ...
Posted by Michael Wonder on 25 Sep 2018
Decision to change the funded brand of epoetin alfa
24 September 2018 - PHARMAC is pleased to announce the approval of an agreement with Novartis for the supply of ...
Posted by Michael Wonder on 13 Sep 2018
PHARMAC defends position not to fund bowel cancer drug
14 September 2018 - PHARMAC is defending its position to not fund a drug recommended to patients with late-stage bowel cancer ...
Posted by Michael Wonder on 13 Sep 2018
Dying cancer patients refused PHARMAC funding
13 September 2018 - Dying patients who suffer a rare reaction to chemotherapy are having to pay for their own ...
Posted by Michael Wonder on 12 Sep 2018
Decision to list nintedanib (Ofev) and remove restrictions from tiotropium bromide (Spiriva)
12 September 2018 - PHARMAC is pleased to announce a decision to list nintedanib (Ofev) and remove the current Special ...
Posted by Michael Wonder on 06 Sep 2018
Proposal on the funding of infliximab, rituximab and tocilizumab
6 September 2018 - PHARMAC is proposing to change how three hospital medicines are managed within the Pharmaceutical Schedule. ...
Posted by Michael Wonder on 06 Sep 2018
Approval of multi-product funding agreement with Novartis
6 September 2018 - PHARMAC is pleased to announce a major funding package involving ten medicines in seven key therapy ...
Posted by Michael Wonder on 03 Sep 2018
Clark accused of cronyism over PHARMAC appointment
1 September 2018 - David Clark is faced with allegations of cronyism after appointing former Labour MP Steve Maharey chair ...
Posted by Michael Wonder on 03 Sep 2018
Patients wanting special funding for anti-depressants turned down by PHARMAC
2 September 2018 - Last year, PHARMAC stopped subsidising two brands of anti-depressants, Arrow Venlafaxine and Effexor XR, and replaced them ...
Posted by Michael Wonder on 31 Aug 2018
New Zealand Pharmaceutical Schedule - 1 September 2018 update
1 September 2018 - The September 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Aug 2018
Expensive life-prolonging drug not an option for many women
30 August 2018 - Wiki Mulholland has the toughest of balancing acts – between staying alive and draining her family ...
Posted by Michael Wonder on 30 Aug 2018
Woman's desperate plea to PHARMAC to fund $6,000/month cancer drug
31 august 2018 - A New Zealand woman is pleading with pharmaceutical giant PHARMAC and MPs to fund an expensive ...
Posted by Michael Wonder on 30 Aug 2018
Proposal to list sapropterin for use in pregnancy by women with phenylketonuria
30 August 2018 - PHARMAC is seeking feedback on a proposal to fund sapropterin tablets, a treatment for the rare ...